Full Spectrum Genomics Cogenics offers a full spectrum of genomic services for research and regulated projects, including DNA and RNA extraction, genotyping, traditional and next generation sequencing, gene expression, QPCR, cell bank characterization, and biobanking. This enables a single partner for turnkey projects and presents opportunities to cross sell instruments, reagents, and data analysis services.

Global Regulatory Capabilities They operate across the United States and Europe with multiple facilities and experience handling regulated work. This regulatory readiness and global footprint position them as a capable partner for multinational trials and cross border sample management with consistent workflows and data.

Pharmacogenomics Focus Their emphasis on pharmacogenomics discovery and validation, along with biomarker research, creates a direct path to pharma and biotech clients seeking companion diagnostics and precision medicine programs. This provides opportunities to propose integrated biomarker development and clinical trial support partnerships.

Growth and Scale With multi site operations and an established revenue base, there is potential to scale through long term outsourcing agreements and larger program engagements, particularly for sequencing throughput, biomarker pipelines, and varied sample handling across sites.

Integrated Differentiation Their heritage from multiple genomics providers and extensive experience offer a differentiated, integrated service portfolio that can outperform single discipline labs, making them an attractive partner for end to end genomic programs and strategic outsourcing relationships.